
    
      COVID19 is an emerging infection with no current approved treatment or prevention. COVID-19
      is increasingly affecting children but convalescent plasma (CP) has not been adequately
      studied in children to date. The study will determine safety of convalescent plasma for
      pediatric patients with severe, or at high risk for severe, COVID-19 disease.
    
  